Natural killer T cell activation inhibits hepatitis B virus replication in vivo.
about
Role of CD1d-restricted NKT cells in microbial immunityHBV pathogenesis in animal models: recent advances on the role of plateletsHepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected HepatocyteThe Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell GenerationiNKT Cells and Their Potential Lipid Ligands during Viral InfectionMouse models of hepatitis B virus infection comprising host-virus immunologic interactionsA glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primatesStealth and cunning: hepatitis B and hepatitis C viruses.Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infectionCurrent progress in the development of therapeutic vaccines for chronic hepatitis B virus infectionImmune-Regulatory Events in the Clearance of HBsAg in Chronic Hepatitis B: Focuses on HLA-DPSignificant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCsAutoreactivity by design: innate B and T lymphocytesInvariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humansRestored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis BImmunosuppression abrogates resistance of young rabbits to Rabbit Haemorrhagic Disease (RHD)Immunology of hepatitis B virus and hepatitis C virus infectionNonclassical MHC-Restricted Invariant Vα6 T Cells Are Critical for Efficient Early Innate Antiviral Immunity in the Amphibian Xenopus laevisAdenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation.NK cell-like behavior of Valpha14i NK T cells during MCMV infection.Paucity of CD4+ natural killer T (NKT) lymphocytes in sooty mangabeys is associated with lack of NKT cell depletion after SIV infection.Non-classical natural killer T cells modulate plasmid DNA vaccine antigen expression and vaccine-elicited immune responses by MCP-1 secretion after interaction with a beta2-microglobulin-independent CD1d.Hepatitis B Virus Immunopathology, Model Systems, and Current TherapiesImmune effectors required for hepatitis B virus clearanceNatural killer cell activation contributes to hepatitis B viral control in a mouse model.Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C.Invariant NKT cell response to dengue virus infection in human.Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infectionDevelopment of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.Antigen expression level threshold tunes the fate of CD8 T cells during primary hepatic immune responsesThe stimulating adventure of KRN 7000.Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus.Alpha-galactosylceramide promotes killing of Listeria monocytogenes within the macrophage phagosome through invariant NKT-cell activationMannose binding lectin genotypes influence recovery from hepatitis B virus infectionInvolvement of natural killer T cells in halothane-induced liver injury in micePathogenesis of hepatitis B virus infectionAccessory cell dependent NK cell mediated PBMC IFN-gamma production is defective in HIV infection.In vivo protection provided by a synthetic new alpha-galactosyl ceramide analog against bacterial and viral infections in murine models.CD1d and invariant NKT cells at the human maternal-fetal interface.
P2860
Q24294851-D7147C2F-FE50-407C-AE44-BDC773C036E9Q24672103-707FCF4B-BA9F-4EDF-9E07-1F5E6756B56BQ26775635-93857F5B-C7E6-46C9-8D92-F2F086CFBF75Q26797344-9F7C34AC-E486-454B-A22E-3CB1F102646AQ26800120-072FF3C4-FCBE-4D20-836E-9C5535F0EB68Q27002598-D7FC40CC-FC36-4544-B0AB-075DA706B6A8Q27303293-8452F1B0-A8E2-4497-AB98-22D6C6734B28Q27470232-1CA6B056-B2CF-4DF7-BDBF-E19089A518FBQ27488372-B26DD6C9-B32F-44F3-A440-136B0510919CQ28076279-E119E460-F22D-425A-95D5-C4743687B445Q28086834-C62D6DDC-9EDD-438D-AC45-A2B8A246970DQ28086980-BC14254B-2777-4238-A6D7-859150EB1578Q28208367-43FD3741-5354-4625-A168-E8E5E130C53BQ28511526-C8505724-24D7-4236-BEA5-3EFD47B52378Q28741248-ED0407C2-A7CE-4182-98F9-E7F099933757Q28972246-9EFDF6DD-AAF9-4E86-96E6-31D2FCB89D16Q29618957-94330661-67DB-4B5B-8F54-599387355E28Q30357670-2A9D83E2-93A1-4D0F-B3A1-8D2C02501716Q30442067-02508F0B-4308-48F0-9E49-0ADADAB46B27Q33352690-07B18397-D7DA-4C66-A65A-4C60AA01F9A0Q33547424-E2FD11BB-9908-4D00-9677-745D10C88AFEQ33553298-D0C3B459-51D7-44BA-BECB-BFE87DB6B936Q33559657-E2BD52F9-64B7-47F3-9E6B-B11EE800909DQ33640225-26BDC490-A391-4A15-8ADF-47DB2C30A572Q33670723-FEA9DC91-895A-4C1E-ADBE-DC47343E7E26Q33744649-62A34F70-453F-4CEA-BA38-2B8106FF2921Q33778714-477E0D34-B2D7-4E17-9297-4C33BA2A48C8Q33781003-2AE70894-921D-4520-BF79-779FBFA30DBFQ33782527-4A53C6BF-325D-4F16-AD0F-18ACC8A0C275Q33788761-D9F9E837-244B-409F-93C9-18CBBDC0901DQ33835059-AFD45F7B-E297-4259-80E7-DD92B65E879AQ33843406-9615A613-28DE-466F-84F0-A6A894751611Q33848840-84987B56-1B7D-44DD-9C69-007B06E4DF05Q33877217-53CAB589-287C-41E2-8942-96B3F5E4EB80Q33883928-324A88AE-B92F-44CF-A07B-1CC24D8BE710Q33924798-20F524F6-BDF7-4551-93D5-80D589E76916Q33925491-8872FE87-1D5D-47BC-BE6C-8F9F4CD28ADDQ34020126-3F23511F-C2CF-4742-8A4D-DD4A1C68C1D5Q34151144-58A5BA09-17FE-4626-B803-4B70D5A062E3Q34160929-9CE07FC6-4838-43EC-9A08-9A02A1AFDA38
P2860
Natural killer T cell activation inhibits hepatitis B virus replication in vivo.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Natural killer T cell activation inhibits hepatitis B virus replication in vivo.
@ast
Natural killer T cell activation inhibits hepatitis B virus replication in vivo.
@en
type
label
Natural killer T cell activation inhibits hepatitis B virus replication in vivo.
@ast
Natural killer T cell activation inhibits hepatitis B virus replication in vivo.
@en
prefLabel
Natural killer T cell activation inhibits hepatitis B virus replication in vivo.
@ast
Natural killer T cell activation inhibits hepatitis B virus replication in vivo.
@en
P2860
P356
P1476
Natural killer T cell activation inhibits hepatitis B virus replication in vivo
@en
P2093
P2860
P304
P356
10.1084/JEM.192.7.921
P407
P577
2000-10-01T00:00:00Z